Corporate Advisory

PharmaDeals v4

PharmaTelevision

Industry Insight and Intelligence

 

Deal-making declines by 18%

Oxford, UK 25 Jan 2012 - Overall pharmaceutical deal-making activity fell by 18% in 2011 as pharmaceutical companies cut R&D expenditure.

Read the full press release

Andy Smith

Oxford, UK 3 October 2011 - PharmaVentures today announced the appointment of Andy Smith as Head of Corporate Finance.

Read the full press release

Astex Pharmaceuticals

PharmaVentures engaged by Astex Pharmaceuticals to seek a buyer for an established full service CMC & Formulation Facility in Pleasanton, CA.

Read the full press release

PharmaVentures News

PharmaVentures acts as exclusive advisor to Sanofi-aventis in landmark divestment deal with Covance

Find out more

New Report Published

The Royalty Rate Report 2011: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector

Find out more

PharmaVentures White Paper

Download a PDF of “Pharmaceutical Royalties in Licensing Deals: No Place for the 25% Rule of Thumb”

Read White Paper

Ping Shek

PharmaVentures Corporate Advisory appoints Ping Shek as Senior Director in Transactions

Read the full press release

PharmaVentures News

PharmaVentures acts as advisor and broker to Dr Reddy’s to identify and secure product marketing opportunities for the Russian/CIS market

Press Release

PharmaDeals V4

Visit our PharmaDeals website to find out more and sign up for a free trial or demo.

PharmaDeals V4

PharmaVentures White Paper

Download a PDF of “Competitive Deal Activity Profiling (CDAP©)”

Read White Paper

PharmaVentures News

PharmaVentures engaged by Avexa to Assist in the Out-licensing of Apricitabine

Read more>

PharmaDeals Launch

New Business Journal launched. Access vital deal making performance analysis on top pharma.

Download Corp-METRx now

BIO-Europe Spring 2012, March 19-21, 2012, Amsterdam, The Netherlands

Recent Clients Include

Recent Previous Clients Include